Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Haemonetics' blood salvage technology:

This article was originally published in Clinica

Executive Summary

Haemonetics has received US FDA 510(k) clearance for a redesigned version of its cardioPAT surgical blood salvage system, which allows surgeons to recover blood lost by a cardiovascular surgery patient during and after their operation, and make the blood available for transfusion back to the patient. The product was originally cleared in January 2005, but Haemonetics decided to postpone its full market release until it had upgraded it with technological improvements that had been identified as necessary during early customer trials. The Braintree, Massachusetts firm said that cardioPAT's market release remains on track for early 2006.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058176

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel